疏水交互作用层析法市场－全球产业规模、份额、趋势、机会和预测：按产品和服务、样品类型、最终用户、地区和竞争格局划分，2021-2031年

全球疏水交互作用层析法市场预计将从 2025 年的 4.2048 亿美元成长到 2031 年的 6.3921 亿美元，复合年增长率为 7.23%。

疏水交互作用层析法(HIC) 是一种利用表面疏水性差异，在高盐环境下透过与疏水配体的可逆相互作用来纯化生物分子的特殊分离技术。市场成长主要受全球单株抗体和重组疫苗产量不断增长的驱动，这些产品需要非变性纯化步骤来有效去除聚集体和变异体。儘管自动化程度不断提高，但由于该技术能够在保持生物活性的同时实现高纯度，因此仍然是下游生物加工的重要组成部分。

然而，由于方法开发的复杂性，市场面临着许多障碍，因为优化盐的类型和浓度以平衡结合能力和产率需要先进的技术专长。虽然这项操作挑战可能会延缓製程验证，但生物製药管线的巨额投资为该产业提供了支持。例如，欧洲製药工业协会联合会（EFPIA）报告称，到2024年，以研发为基础的製药业将在欧洲的研发领域投资约550亿欧元，这凸显了推动复杂疗法研发的强大资金投入，而这些疗法需要此类先进的纯化技术。

市场驱动因素

全球生物製药产业的快速成长正成为疏水交互作用层析法（ HIC）市场扩张的主要催化剂。随着製造商扩大生产规模以应对慢性病患者数量的成长，对能够处理更高通量的下游加工技术的需求也随之增加。生产基础设施的大规模资本投资印证了这个趋势。例如，诺和诺德在2024年6月宣布，将投资41亿美元在北卡罗来纳州克莱顿新建一座工厂，以扩大其註射剂的供应。如此大规模的产能投资将直接扩大纯化管柱和树脂的安装基础，因为HIC对于确保这些大分子药物的稳定性和有效性至关重要。

同时，单株抗体和重组蛋白的激增需求也推动了这种分离技术的应用。疏水相互作用层析（HIC）因其能够在不损害分子结构完整性的前提下去除聚集体和宿主细胞蛋白，在抗体工作流程中备受青睐。这种强劲的研发动能也体现在监管层面。美国食品药物管理局（FDA）于2024年12月发布了《2024年新药核准报告》，其中列出了50种新分子实体（NME）的核准，凸显了复杂生物製药的持续涌入。为了支持这些药物的商业化，契约製造生产商正在扩展其纯化能力，例如三星生物製剂公司于2024年10月获得了一份价值约12.4亿美元的创纪录的生产合约。这进一步强调了该行业对高纯度治疗性蛋白质的先进生物製程解决方案的依赖。

市场挑战

全球疏水交互作用层析法(HIC) 市场成长面临的主要挑战之一是方法开发本身的复杂性，这需要先进的技术专长才能有效实施。 HIC 需要精确优化关键参数，例如盐的类型和浓度，并且结合能力和蛋白质稳定性之间的微妙平衡至关重要。与更简单的纯化技术不同，HIC 常常表现出反直觉的行为，操作条件的微小偏差都可能导致产量显着下降或蛋白质变性。这种对先进技术的高度依赖造成了下游加工的瓶颈。企业难以招募和留住执行此复杂开发週期所需的高技能人才，导致製程验证和产品商业化进程的延误。

生物製药生产领域日益严重的人才短缺进一步加剧了这项营运瓶颈。缺乏能够管理先进纯化平台的合格科学家和技术人员，限制了该行业扩大规模以满足不断增长的需求。根据国家生物製程研究与培训研究所 (NIBRT) 预测，到 2027 年，生物製药产业预计将需要超过 21,000 名新人才，而目前每年却面临约 3,000 名技术毕业生的严重缺口。这种技术人才短缺直接阻碍了疏水交互作用层析法等复杂技术的广泛高效应用，儘管生物製药研发管线实力雄厚，但仍阻碍了市场扩张。

市场趋势

在抗体药物复合体(ADC) 纯化中采用疏水交互作用层析法，从根本上重塑了市场对技术的需求。与标准抗体不同，ADC 由于偶联了细胞毒性有效载荷，具有显着的疏水异质性，因此这种分离模式对于基于药物抗体比 (DAR) 进行有效分类至关重要。该技术使生产商能够在去除未结合抗体的同时，分离出标靶治疗药物。这种向复杂偶联药物的结构性转变得到了大规模生产投资的支持。例如，Astra Zeneca于 2024 年 5 月宣布投资 15 亿美元，在新加坡建立专门用于此类标靶治疗的生产设施，从而确保了对能够处理偶联分子的分离介质的持续需求。

此外，基因治疗和病毒载体纯化领域应用的不断拓展，正催生出与传统蛋白质工作流程截然不同的成长轨迹。腺结合病毒(AAV) 的生产正日益利用细微的疏水性差异，将含有遗传有效载荷的完整衣壳与空衣壳分离，这对于最大限度地提高治疗效果和降低病毒总载量至关重要。不断成长的先进治疗方法临床研发管线也推动了这一领域的发展。根据美国基因与细胞治疗学会 (ASGCT) 2024 年 4 月发布的报告，基因、细胞和 RNA 疗法的研发管线已达 4,096 种药物，这表明针对病毒载体优化的纯化方法的应用范围正在不断扩大。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5. 全球疏水交互作用层析法市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品/服务分类（树脂、层析管、HIC层析管、缓衝溶液、服务等）
  • 依样本类型（单株抗体、疫苗、其他样本）
  • 按最终用户（製药/生物製药公司、CRO/CMO、研究/学术机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美疏水交互作用层析法市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲疏水交互作用层析法市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区疏水交互作用层析法市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲疏水交互作用层析法市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲疏水交互作用层析法市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球疏水交互作用层析法市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience
• Geno Technology Inc.
• Axel Semrau GmbH
• PerkinElmer Inc.
• Cecil Instrumentation Services Ltd
• Hitachi High-Tech Corporation
• Agilent Technologies, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Hydrophobic Interaction Chromatography Market is projected to expand from USD 420.48 Million in 2025 to USD 639.21 Million by 2031, growing at a CAGR of 7.23%. Hydrophobic Interaction Chromatography (HIC) is a specialized separation method that purifies biomolecules by leveraging differences in surface hydrophobicity through reversible interactions with hydrophobic ligands in high-salt environments. Market growth is largely driven by the rising global production of monoclonal antibodies and recombinant vaccines, which require non-denaturing polishing steps to remove aggregates and variants effectively. Because this technology maintains biological activity while achieving high purity, it remains a fundamental component of downstream bioprocessing, regardless of broader automation trends.

However, the market encounters a significant obstacle due to the complexity of method development, as optimizing salt type and concentration to balance binding capacity and yield requires considerable technical expertise. Although this operational challenge can delay process validation, the sector is supported by substantial investment in biologic drug pipelines. For instance, the European Federation of Pharmaceutical Industries and Associations reported that in 2024, the research-based pharmaceutical industry invested approximately €55,000 million in R&D across Europe, underscoring the strong financial commitment propelling the development of complex therapeutics that demand such sophisticated purification technologies.

Market Driver

The rapid growth of the global biopharmaceutical industry serves as a primary catalyst for the expansion of the hydrophobic interaction chromatography market. As manufacturers scale operations to address the increasing prevalence of chronic diseases, there is a concurrent need for downstream processing technologies capable of managing higher throughput. This trend is illustrated by major capital investments in production infrastructure; for example, Novo Nordisk announced in June 2024 a $4.1 billion commitment to build a new facility in Clayton, North Carolina, specifically to boost the supply of injectable treatments. Such significant capacity investments directly increase the installation base for purification columns and resins, as HIC remains critical for ensuring the stability and potency of these large-molecule therapeutics.

Simultaneously, the surging demand for monoclonal antibodies and recombinant proteins drives the adoption of this separation technique. HIC is particularly esteemed in antibody workflows for its ability to clear aggregates and host cell proteins without compromising the molecule's structural integrity. This intense development activity is reflected in the regulatory landscape; the U.S. Food and Drug Administration's 'Novel Drug Approvals for 2024' report from December 2024 noted the approval of 50 new molecular entities, highlighting a continuous influx of complex biologics. To support this commercialization, contract manufacturing organizations are expanding their purification capabilities, as seen in October 2024 when Samsung Biologics secured a record manufacturing contract worth approximately $1.24 billion, further validating the industry's reliance on advanced bioprocessing solutions for high-purity therapeutic proteins.

Market Challenge

The primary challenge restricting the growth of the Global Hydrophobic Interaction Chromatography Market is the inherent complexity associated with method development, which requires substantial technical expertise to execute effectively. HIC demands precise optimization of critical parameters, such as salt type and concentration, to manage the delicate balance between binding capacity and protein stability. Unlike simpler purification techniques, HIC often exhibits non-intuitive behaviors where slight deviations in operating conditions can result in significant yield losses or protein denaturation. This high dependency on specialized knowledge creates a bottleneck in downstream processing, as companies struggle to recruit and retain personnel with the advanced skills needed to navigate these intricate development cycles, thereby delaying process validation and product commercialization.

This operational constraint is severely exacerbated by a widening workforce gap within the biopharmaceutical manufacturing sector. The shortage of qualified scientists and engineers capable of managing sophisticated purification platforms limits the industry's ability to scale operations to meet rising demand. According to the National Institute for Bioprocessing Research and Training (NIBRT), the biopharma sector was projected in 2024 to require over 21,000 new jobs by 2027, yet it faces a critical forecasted shortfall of approximately 3,000 skilled graduates annually. This deficit in available technical talent directly impedes the broader adoption and efficient implementation of complex technologies like hydrophobic interaction chromatography, stifling market expansion despite the robust pipeline of biologic drugs.

Market Trends

The adoption of hydrophobic interaction chromatography for antibody-drug conjugate (ADC) purification is fundamentally reshaping technical requirements within the market. Unlike standard antibodies, ADCs possess significant hydrophobic heterogeneity due to the conjugation of cytotoxic payloads, necessitating this separation mode to effectively resolve species based on the drug-antibody ratio (DAR). This capability allows manufacturers to isolate the target therapeutic profile while removing unconjugated antibodies. This structural shift toward complex conjugated modalities is evidenced by substantial manufacturing commitments; for instance, AstraZeneca announced in May 2024 a $1.5 billion capital outlay to establish a facility in Singapore dedicated to these targeted treatments, ensuring sustained demand for separation media capable of handling conjugated molecules.

Furthermore, the expansion of applications in gene therapy and viral vector purification creates a distinct growth trajectory separate from traditional protein workflows. In adeno-associated virus (AAV) manufacturing, this technique is increasingly utilized to separate full capsids containing the genetic payload from empty capsids by exploiting subtle hydrophobic differences, which is vital for maximizing therapeutic potency and reducing total viral load. The segment's expansion is supported by a widening clinical pipeline for advanced therapies; according to the American Society of Gene & Cell Therapy's April 2024 report, the pipeline for gene, cell, and RNA therapies reached 4,096 candidates, indicating a broadening application base for purification methods optimized for viral vectors.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience
• Geno Technology Inc.
• Axel Semrau GmbH
• PerkinElmer Inc.
• Cecil Instrumentation Services Ltd
• Hitachi High-Tech Corporation
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Hydrophobic Interaction Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydrophobic Interaction Chromatography Market, By Product and Services

• Resins
• Columns
• HIC Columns
• Buffers
• Services
• Others

Hydrophobic Interaction Chromatography Market, By Sample Type

• Monoclonal Antibodies
• Vaccines
• Other Samples

Hydrophobic Interaction Chromatography Market, By End User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations and Contract Manufacturing Organizations
• Research and Academic Institutes
• others

Hydrophobic Interaction Chromatography Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hydrophobic Interaction Chromatography Market.

Available Customizations:

Global Hydrophobic Interaction Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hydrophobic Interaction Chromatography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product and Services (Resins, Columns, HIC Columns, Buffers, Services, Others)
  • 5.2.2. By Sample Type (Monoclonal Antibodies, Vaccines, Other Samples)
  • 5.2.3. By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations and Contract Manufacturing Organizations, Research and Academic Institutes, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hydrophobic Interaction Chromatography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product and Services
  • 6.2.2. By Sample Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product and Services
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product and Services
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Hydrophobic Interaction Chromatography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product and Services
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By End User

7. Europe Hydrophobic Interaction Chromatography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product and Services
  • 7.2.2. By Sample Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product and Services
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product and Services
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product and Services
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product and Services
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Hydrophobic Interaction Chromatography Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product and Services
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Hydrophobic Interaction Chromatography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product and Services
  • 8.2.2. By Sample Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product and Services
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product and Services
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product and Services
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product and Services
      • 8.3.4.2.2. By Sample Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Hydrophobic Interaction Chromatography Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product and Services
      • 8.3.5.2.2. By Sample Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Hydrophobic Interaction Chromatography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product and Services
  • 9.2.2. By Sample Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product and Services
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product and Services
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Hydrophobic Interaction Chromatography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product and Services
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By End User

10. South America Hydrophobic Interaction Chromatography Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product and Services
  • 10.2.2. By Sample Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product and Services
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product and Services
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Hydrophobic Interaction Chromatography Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product and Services
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hydrophobic Interaction Chromatography Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sartorius AG
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Tosoh Bioscience
• 15.5. Geno Technology Inc.
• 15.6. Axel Semrau GmbH
• 15.7. PerkinElmer Inc.
• 15.8. Cecil Instrumentation Services Ltd
• 15.9. Hitachi High-Tech Corporation
• 15.10. Agilent Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer